Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4269875, 7 pages
https://doi.org/10.1155/2017/4269875
Review Article

Effect of Calcium Channel Blockers on Lower Urinary Tract Symptoms: A Systematic Review

1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
2Punjab University College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan
3Department of Urology (Unit-I), Mayo Hospital, Lahore, Pakistan

Correspondence should be addressed to Muhammad Salman; moc.liamg@2105ksm and Amer Hayat Khan; moc.liamg@6002remard

Received 26 May 2017; Revised 21 August 2017; Accepted 12 September 2017; Published 16 October 2017

Academic Editor: Guiming Liu

Copyright © 2017 Muhammad Salman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Abrams, “New words for old: Lower urinary tract symptoms for “prostatism”,” British Medical Journal, vol. 308, no. 6934, pp. 929-930, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. C. R. Chapple, A. J. Wein, P. Abrams et al., “Lower urinary tract symptoms revisited: a broader clinical perspective,” European Urology, vol. 54, no. 3, pp. 563–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Wein, “Classification of neurogenic voiding dysfunction,” The Journal of Urology, vol. 125, no. 5, pp. 605–609, 1981. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Wein, “Pathophysiology and classification of voiding dysfunction,” in Campbell-Walsh Urology, A. J. Wein, L. R. Kavoussi, A. C. Novick, A. W. Partin, and C. A. Peters, Eds., pp. 1973–1985, Saunders/Elsevier, Philadelphia, Penn, USA, 2007. View at Google Scholar
  5. J. W. Wegener, V. Schulla, T.-S. Lee et al., “An essential role of Cav1.2 L-type calcium channel for urinary bladder function,” The FASEB Journal, vol. 18, no. 10, pp. 1159–1161, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. V. C. Lowe and L. Noronha-Blob, “Effect of extracellular Ca2+ on cholinergic, KCl and phorbol ester-mediated phosphoinositide turnover and guinea pig urinary bladder contraction,” European Journal of Pharmacology, vol. 195, no. 2, pp. 273–279, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Hamada, Y. Sasaki, N. Taniguchi et al., “Anticholinergic and calcium antagonistic activities of NS-21 contribute to the inhibition of rat urinary bladder contractions,” General Pharmacology: The Vascular System, vol. 29, no. 5, pp. 771–778, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Horváth, Z. Morvay, M. Kovács, A. Szilágyi, and M. Szikszay, “Drugs acting on calcium channels modulate the diuretic and micturition effects of dexmedetomidine in rats,” Life Sciences, vol. 59, no. 15, pp. 1247–1257, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” Annals of Internal Medicine, vol. 151, no. 4, pp. 65–94, 2009. View at Google Scholar · View at Scopus
  10. D. Moher, L. Shamseer, and M. Clarke, “Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement,” Systematic Reviews, vol. 4, no. 1, article 1, 2015. View at Publisher · View at Google Scholar
  11. L. Shamseer, D. Moher, M. Clarke et al., “Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: Elaboration and explanation,” British Medical Journal, vol. 349, article g7647, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Wells, B. Shea, D. O'Connell et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses, Ottawa Health Research Institute, Ottawa, Canada, 2011, Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  13. R. Herzog, M. J. Álvarez-Pasquin, C. Díaz, J. L. Del Barrio, J. M. Estrada, and Á. Gil, “Are healthcare workers intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review,” BMC Public Health, vol. 13, no. 1, pp. 113–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. V. Hernandez, V. Pasupuleti, V. A. Benites-Zapata, P. Thota, A. Deshpande, and F. R. Perez-Lopez, “Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis,” European Journal of Cancer, vol. 51, no. 18, pp. 2747–2758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Hughes, M. A. Coles, and A. Joyce, “Calcium channel blocker associated lower urinary tract symptoms in males: An Australian retrospective observational study,” Quality in Primary Care, vol. 19, no. 4, pp. 223–231, 2011. View at Google Scholar · View at Scopus
  16. E. S. Elhebir, Calcium Antagonists-Induced Lower Urinary Tract Symptoms [Doctor of Philosophy], Curtin University of Technology, Perth, Western Australia, May 2011.
  17. S. A. Hall, G. R. Chiu, D. W. Kaufman, G. A. Wittert, C. L. Link, and J. B. McKinlay, “Commonly used antihypertensives and lower urinary tract symptoms: Results from the Boston Area Community Health (BACH) Survey,” BJU International, vol. 109, no. 11, pp. 1676–1684, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ito, M. Taga, K. Tsuchiyama, H. Akino, and O. Yokoyama, “IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: Posthoc analyses of a lower urinary tract symptoms population,” Neurourology and Urodynamics, vol. 32, no. 1, pp. 70–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. E. T. Kok, B. W. Schouten, A. M. Bohnen, F. P. M. W. Groeneveld, S. Thomas, and J. L. H. R. Bosch, “Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the krimpen study,” The Journal of Urology, vol. 181, no. 2, pp. 710–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. World Health Organization. Global Health Observatory (GHO), Raised Blood Pressure. Situations and trends. Availabe from: http://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/.